Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan

Abstract

The independent risk factors for death in patients admitted for asthma exacerbation have not been thoroughly investigated. This study aimed to investigate these independent risk factors and the relationship between mortality and the prescription patterns of anti-asthmatic medications in patients admitted for asthma exacerbation. Using a nested case-control design, we identified 267 cases (death after asthma admission) and 1035 controls (survival after asthma admission) from the Taiwan National Health Insurance Research Database (NHIRD) from 2001 to 2010. Conditional logistic regressions were used to estimate the odds ratios (ORs) with 95% confidence intervals (CIs). We identified the independent risk factors for death as the comorbidities of pneumonia (aOR 3.82, 95% CI 2.41-6.05), genitourinary disease (aOR 1.75, 95% CI 1.17-2.62), septicemia (aOR 4.26, 95% CI 2.61-6.94), diabetes mellitus (aOR 2.10, 95% CI 1.30-3.38), arrhythmia (aOR 2.00, 95% CI 1.14-3.50), and a history of asthmatic hospitalization (aOR 4.48, 95% CI 2.77-7.25). Moreover, the use of short-acting β 2 -agonist (SABA) and the dosage of oral corticosteroids (OCSs) >70 mg prednisolone during previous hospitalization (all p < 0.05) and the dosage of OCSs ≥110 mg prednisolone/month (aOR 2.21, 95% CI 1.08-4.50) during outpatient treatment independently increased the risk of death. The inhaled corticosteroids (ICSs) ≥4 canisters/ year (aOR 0.39, 95% CI 0.19-0.78) independently reduced the risk of death. Specific comorbidities, asthma severity, and prescription patterns of SABA, OCSs, and ICSs were independently associated with mortality in patients admitted for asthma exacerbation. These results can be utilized to help physicians identify asthmatic patients who are at a higher mortality risk and to refine the management of the condition.npj Primary Care Respiratory Medicine (2020) 30:7 ; https://doi.

Management of Children with Acute Asthma Attack: A RAND/UCLA Appropriateness Approach

“…In the second round, the percentage of participants who considered pMDI with spacer equal to nebulizer increased but not enough to reach the agreement of 75% despite the evidence of its superiority in case of mild and moderate attacks [ 53 , 54 , 55 , 56 , 57 , 58 ]. Conversely, nebulization represents the ideal route of administration in case of a severe episode and need of oxygen supplementation, as well as in case of poor response to puffs.…”

“…During an acute asthma attack, the measurement of lung function by FEV 1 (forced expiratory volume in 1 s) or PEF is strongly recommended whenever possible, without delaying therapy. These tests define the severity of the attack (mild for PEF or FEV 1 values >80%, moderate for values between 60 and 80% and severe if PEF or FEV 1 are <60%) and assess the response to therapy [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 ...…”

The Association Between Asthma and Narcolepsy: A Nationwide Case-Control Study in Taiwan

“…Previous studies have reported that corticosteroid treatment for patients with asthma may decrease the risk of asthma-related death, 33 lung cancer, 34 and chronic kidney disease (CKD). 23 However, some studies have found that the effects of corticosteroids vary with other diseases such as cancer, schizophrenia, and dry eye syndrome.…”

Asthma Mortality and Hospitalizations in Mexico from 2010 to 2018: Retrospective Epidemiologic Profile

“…Our results agree with Chang et al reported that in-hospital infection (pneumonia, genitourinary disease, and septicemia) were independent risk factors of death in patients admitted for asthma exacerbation. [ 37 ].…”